Home>
Stocks>
Brawn Biotech Ltd

Brawn Biotech Ltd (530207)

₹26.07▲4.99%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Brawn Biotech Ltd share Performance

₹26.07
₹26.07
₹26.07
Day's Volatility:
₹14.36
₹26.8
₹26.07
44.92%
Low
52 Weeks Volatility:47.72%
High
2.80%

Returns %
1 Month Return	18.24 %
3 Month Return	39.03 %
1 Year Return	52.8 %

Market Stats
Previous Close	₹24.83
Open	₹26.07
Volume	2,132.00
Upper Circuit	-
Lower Circuit	-
Market Cap	₹7.45Cr

Company Information

Brawn Pharmaceuticals, established in 1985, has evolved into a fully-integrated healthcare group, extending its reach across India and multiple other countries worldwide. The company is registered with major healthcare and government institutions both in India and abroad, and is managed by an experienced team of industry experts. Their product portfolio covers a wide range of therapeutic sectors, like antibiotics, diabetes, and skin care, to name a few. Additionally, Brawn is further supported by an experienced team of certified consultants to ensure a competitive edge in the market. This success has enabled them to be among the leading Indian healthcare product distributors, paving the way for further expansion.

Share Price: ₹26.07 per share as on 02 May, 2024 04:01 PM
Market Capitalisation: ₹7.45Cr as of today
Revenue: ₹0.12Cr as on June 2023 (Q2 23)
Net Profit: ₹0.04Cr as on June 2023 (Q2 23)
Listing date: 01 Jan, 0001

Organisation	Brawn Biotech Ltd
Headquarters	New Delhi
Industry	Trading
E-voting on shares	Click here to vote

Fundamentals of Brawn Biotech Ltd

Insights on Brawn Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 45.69% to 46.01% in Mar 2024 quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, Brawn Biotech stock has moved up by 15.7%
NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.9% return, outperforming this stock by 148.3%
NO EFFECT
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 54.4% return, outperforming this stock by 1.6%
NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 53.72% to 53.64% in Mar 2024 quarter
NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 0.59% to 0.35% in Mar 2024 quarter